Virtus ETF Advisers’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-61,668
| Closed | -$335K | – | 732 |
|
|
2024
Q4 | $335K | Buy |
61,668
+33,029
| +115% | +$202K | 0.14% | 223 |
|
|
2024
Q3 | $207K | Hold |
28,639
| – | – | 0.1% | 250 |
|
|
2024
Q2 | $311K | Buy |
28,639
+10,674
| +59% | +$137K | 0.15% | 223 |
|
|
2024
Q1 | $337K | Buy |
17,965
+2,585
| +17% | +$59.6K | 0.18% | 219 |
|
|
2023
Q4 | $333K | Buy |
15,380
+10,140
| +194% | +$201K | 0.21% | 201 |
|
|
2023
Q3 | $108K | Sell |
5,240
-680
| -11% | -$19.6K | 0.07% | 327 |
|
|
2023
Q2 | $278K | Sell |
5,920
-1,533
| -21% | -$76.3K | 0.17% | 219 |
|
|
2023
Q1 | $313K | Buy |
7,453
+133
| +2% | +$5.72K | 0.17% | 196 |
|
|
2022
Q4 | $279K | Sell |
7,320
-68
| -0.9% | -$2.6K | 0.15% | 296 |
|
|
2022
Q3 | $289K | Buy |
7,388
+107
| +1% | +$4.14K | 0.12% | 279 |
|
|
2022
Q2 | $235K | Sell |
7,281
-2,313
| -24% | -$77.5K | 0.09% | 309 |
|
|
2022
Q1 | $318K | Hold |
9,594
| – | – | 0.14% | 172 |
|
|
2021
Q4 | $408K | Buy |
9,594
+3,314
| +53% | +$139K | 0.15% | 140 |
|
|
2021
Q3 | $278K | Sell |
6,280
-573
| -8% | -$26.3K | 0.12% | 209 |
|
|
2021
Q2 | $389K | Sell |
6,853
-1,999
| -23% | -$141K | 0.16% | 194 |
|
|
2021
Q1 | $663K | Buy |
8,852
+241
| +3% | +$19.8K | 0.28% | 114 |
|
|
2020
Q4 | $745K | Sell |
8,611
-7,531
| -47% | -$555K | 0.31% | 91 |
|
|
2020
Q3 | $987K | Buy |
16,142
+1,360
| +9% | +$68.9K | 0.52% | 77 |
|
|
2020
Q2 | $615K | Buy |
14,782
+6,710
| +83% | +$244K | 0.29% | 110 |
|
|
2020
Q1 | $232K | Sell |
8,072
-681
| -8% | -$39.4K | 0.1% | 265 |
|
|
2019
Q4 | $632K | Buy |
8,753
+4,769
| +120% | +$587K | 0.1% | 175 |
|
|
2019
Q3 | $559K | Sell |
3,984
-661
| -14% | -$111K | 0.11% | 178 |
|
|
2019
Q2 | $850K | Buy |
4,645
+2,000
| +76% | +$341K | 0.18% | 169 |
|
|
2019
Q1 | $421K | Sell |
2,645
-303
| -10% | -$43.9K | 0.9% | 34 |
|
|
2018
Q4 | $282K | Buy |
2,948
+77
| +3% | +$8.81K | 0.05% | 133 |
|
|
2018
Q3 | $406K | Sell |
2,871
-2,052
| -42% | -$317K | 0.04% | 161 |
|
|
2018
Q2 | $771K | Buy |
4,923
+152
| +3% | +$23.9K | 0.68% | 51 |
|
|
2018
Q1 | $768K | Buy |
4,771
+2,584
| +118% | +$439K | 0.67% | 80 |
|
|
2017
Q4 | $360K | Sell |
2,187
-2,047
| -48% | -$198K | 0.45% | 76 |
|
|
2017
Q3 | $264K | Buy |
4,234
+388
| +10% | +$30.5K | 0.04% | 135 |
|
|
2017
Q2 | $306K | Sell |
3,846
-1,991
| -34% | -$144K | 0.05% | 117 |
|
|
2017
Q1 | $415K | Buy |
5,837
+560
| +11% | +$32.8K | 0.07% | 114 |
|
|
2016
Q4 | $269K | Sell |
5,277
-3,497
| -40% | -$165K | 0.08% | 123 |
|
|
2016
Q3 | $404K | Hold |
8,774
| – | – | 0.2% | 79 |
|
|
2016
Q2 | $264K | Buy |
8,774
+4,172
| +91% | +$139K | 0.2% | 76 |
|
|
2016
Q1 | $148K | Buy |
+4,602
| New | +$162K | 0.2% | 121 |
|
Other funds holding SAGE
MAP
CP
TAL
DTC
BFM